The diagnosis and management of episcleritis and scleritis.
D001167:Arteritis / Q000150:complications; D001172:Arthritis, Rheumatoid / Q000150:complications; D001528:Behcet Syndrome / Q000150:complications; D002986:Clinical Trials as Topic; D003638:Deafness / Q000150:complications; D004485:Eczema / Q000150:complications; D004837:Epinephrine / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000150:complications; D005128:Eye Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D013700:Giant Cell Arteritis / Q000150:complications; D006073:Gout / Q000150:complications; D014890:Granulomatosis with Polyangiitis / Q000150:complications; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010488:Polyarteritis Nodosa / Q000150:complications; D011239:Prednisolone / Q000627:therapeutic use*; D012214:Rheumatic Heart Disease / Q000150:complications; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications; D012393:Rosacea / Q000150:complications; D012590:Sclera; D013210:Staphylococcus; D013256:Steroids / Q000627:therapeutic use*; D014717:Vertigo / Q000150:complications
D013256:Steroids; D011239:Prednisolone; D010113:Oxyphenbutazone; D007213:Indomethacin; D004837:Epinephrine